OSE Immunotherapeutics Receives a Milestone Payment of €5.4 Million From Bpifrance for SIRPα-Antagonist Monoclonal Antibody BI 765063

    NEXT STORY
    Oasmia presents Q1 report through audiocast on September 26
    PREV STORY
    Thymidine Kinase 1 can be used for early detection of therapy response in breast cancer treatment
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Zai Lab Limited Announces Dosing of First Patient in Phase 3 Registration Trial of ZL-2306 (niraparib) for Treatment of Ovarian Cancer

    SHANGHAI, China, Sept. 29, 2017 (GLOBE NEWSWIRE) -- Zai Lab Limited (NASDAQ:ZLAB), a Shanghai-based ...

    author_avatar
    NASDAQ Market News

    ACTRESS MAGGIE Q TO RECEIVE WORLD TOURISM HUMANITARIAN AWARD 2018 FOR HER DEDICATED WORK ON BEHALF OF KAGENO, AN NGO WITH PROJECTS IN KENYA AND RWANDA

    NOVEMBER 5, 2018, WORLD TRAVEL MARKET LONDONNew York, New York, Oct. 04, 2018 (GLOBE ...

    author_avatar
    NASDAQ Market News

    Oncology Venture meddelar nyheter om sina kliniska utvecklingsprojekt dovitinib, 2X-121 och LiPlaCis

    author_avatar
    NASDAQ Market News